Telomir Pharmaceuticals TELO
NASDAQ TELO
$1.01 -0.01 (-0.98%)
At close: Oct 22, 2026 · 4:00 PM EDT

Telomir Pharmaceuticals (TELO) Revenue (2024 - 2025)

Updated

Analysis

Telomir Pharmaceuticals (TELO) Revenue (2024 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 22.97 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 25.40 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 16.99 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn 16.61 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 14.41 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 15.38 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn 10.05 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn 7.80 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn 15.03 Bn
10 Telomir Pharmaceuticals 69.46 Mn 48.89 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 44,182.00
Jun 30, 2025 22.00
Mar 31, 2025 7,954.00
Sep 30, 2024 15,445.00
Jun 30, 2024 25,493.00
Mar 31, 2024 -4.34 Mn
API Access

Telomir Pharmaceuticals Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=TELO&period=max&api_key=YOUR_API_KEY